Bajaj Healthcare share rose after the company announced that it has entered into a definitive CDMO contract with UK/EU based companies for 15 new active pharmaceutical ingredients (APIs)
The mentioned site has already received approval from the US FDA (US Food and Drug Administration) and EU, as per the filing
Bajaj Healthcare share price surged 6.78 per cent at Rs 404.30 per share on the BSE in Monday's intraday deals
Q1FY25 company results: Cosco India, Bajaj Healthcare, Reliance Infrastructure, and Coffee Day Enterprises will be releasing their quarter results on Aug 14